Sina entertainment news: due to the author’s discomforts, the comic book “mantra fight back”, which is being serialized in “weekly junior jump”, will be temporarily suspended from the magazine released on June 21.
In the first quarter of 2021, the net profit of shareholders of Shijiazhuang Pharmaceutical Group increased by 26.9% year on year to RMB 1472 million, which was slightly better than the market expectation and our expectation, mainly due to the stronger than expected fee control. In the first quarter of 2021, revenue increased by 9.9% year-on-year to RMB 6734 million. The year-on-year growth rate of revenue in the proprietary medicine sector decreased slightly to 9.1%, mainly affected by the decline in sales growth of enbip, keaili and jinyouli. The revenue of API and other sectors increased by 5.1% on a year-on-year basis, mainly due to the rising price of vitamin C API. We believe that the net profit of shareholders in 2021 will increase by 6.8% year-on-year (or 24.2% year-on-year after adjustment). Considering that 1) the annual sales volume of NBP is expected to be slightly less than that in 2020, the growth rate of its sales volume is expected to increase by 10%